Qiagen N.V.

QGEN · NEW YORK STOCK EXCHANGE INC.

Biological Product (except Diagnostic) Manufacturing · Netherlands

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of December 31, 2020, QIAGEN employed more than 5,600 people in over 35 locations worldwide.

Market Data

Price $43.00 -0.33 (-0.76%)

Market Cap$8.89B

P/E Ratio20.93

EPS$—

52W High$57.82

52W Low$38.13

Beta0.76

Data from Finnhub · Updated Mar 11, 2026